New York Assembly Bill A05444

New York 2025-2026 Regular Session

• Introduced: 2/14/25
• Refer: 2/14/25
• Refer: 1/7/26

Caption

Provides hospital, surgical and medical insurance coverage for perimenopausal and menopausal care and treatment.

Impact

The implications of A05444 are significant for state healthcare laws as it explicitly introduces requirements for insurance providers to include perimenopausal and menopausal care in their offerings. This bill represents a shift towards greater recognition of women's health needs and addresses existing gaps in insurance coverage for these stages of life. By preventing additional costs due to deductibles or co-payments, it emphasizes accessibility and affordability of essential treatments. Such statutory amendments may also stimulate discussions around broader healthcare reforms to enhance women's health services across various conditions.

Summary

Bill A05444 aims to amend the New York insurance law to mandate coverage for perimenopausal and menopausal care and treatment by healthcare providers. Specifically, it requires that policies offering hospital, surgical, or medical care must include coverage for related treatments without subjecting them to annual deductibles, co-payment fees, or coinsurance. The symptoms addressed by the bill include irregular menstrual periods, hot flashes, and other complications associated with perimenopause and menopause, highlighting a commitment to improve healthcare for women during significant transitions in their reproductive health.

Contention

While advocates for women's health rights view A05444 as a critical step towards safeguarding the health of women experiencing menopause, some stakeholders may argue about the financial implications for insurance companies. There may be concerns regarding the potential increase in premiums if additional coverage expands significantly. Some critics might also question the future sustainability of mandating such coverage, as insurers have to navigate balancing comprehensive care with overall healthcare costs. Thus, the bill could evoke debate over how to best formulate policies that ensure health equity while managing economic feasibility.